
Retinitis Pigmentosa Therapeutics Enter New Era as Gene-Agnostic & Intravitreal Therapies Redefine Competitive Landscape
Retinitis Pigmentosa therapies evolve beyond gene-specific fixes with gene-agnostic, intravitreal, and optogenetic advances reshaping the treatment landscape. AUSTIN, TX, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- The treatment paradigm …